文献速递临床微生物分子诊断

fosA基因对多菌种产KPC临床分离株磷霉素药敏试验准确性的影响

The Role of fosA in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates.
PubMed 文献 · J Clin Microbiol · 2019-09-24

本研究以2008至2016年单中心收集的96株产KPC多菌种临床分离株为对象,比较Etest、纸片扩散法与琼脂稀释法检测磷霉素敏感性的差异,并结合全基因组测序分析fosA基因。结果显示琼脂稀释法敏感率88%,Etest为63%,纸片扩散法为70%;fosA阳性与较高MIC分布相关,加入膦甲酸钠可纠正部分纸片扩散法的重大误差。

要点

  • 琼脂稀释法敏感率88%,高于Etest的63%和纸片扩散法的70%。
  • fosA在已测序分离株中检出率为80%,且与较高磷霉素MIC相关。
  • 膦甲酸钠可抑制fosA,使纸片扩散法抑菌圈增大并纠正部分重大误差。

核心结论

  • fosA基因影响临床实验室常用药敏方法(Etest和纸片扩散法)与琼脂稀释法相比的准确性。
  • 需进一步研究fosA对临床结局的影响。

研究设计与样本

  • 单中心回顾性研究,纳入2008至2016年收集的96株产KPC多菌种临床分离株。
  • 采用葡萄糖-6-磷酸补充的磷霉素Etest、纸片扩散法和琼脂稀释法进行药敏试验,并用CLSI大肠埃希菌折点判读。
  • 利用全基因组测序数据通过NCBI AMRFinder和自定义HMM搜索检测磷霉素耐药基因。

主要发现

  • 总体敏感率:Etest为63%(60/96),纸片扩散法为70%(67/96),琼脂稀释法为88%(84/96)。
  • fosA在80%(70/88)的已测序分离株中检出,具有菌种特异性关联和等位基因。
  • fosA阳性分离株与较高MIC分布相关。
  • 加入膦甲酸钠后,fosA阳性分离株的纸片扩散法抑菌圈直径较fosA阴性株显著增大。
  • 加入膦甲酸钠纠正了与琼脂稀释法分类一致性中的10/14(71%)重大误差。

关键数值与推荐

  • 药敏判读采用CLSI大肠埃希菌折点。
  • 纸片扩散法增敏试验使用膦甲酸钠抑制fosA。

临床怎么用

  • 临床微生物实验室应意识到fosA可导致产KPC多菌种分离株磷霉素药敏试验(Etest和纸片扩散法)结果不准确。
  • 纸片扩散法联合膦甲酸钠可能减少fosA阳性菌株的重大误差,但需进一步验证。

局限性

  • 单中心研究,样本量有限(96株)。
  • fosA对临床结局的影响尚未确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

With multidrug-resistant (MDR) Enterobacterales on the rise, a nontoxic antimicrobial agent with a unique mechanism of action such as fosfomycin seems attractive. However, establishing accurate fosfomycin susceptibility testing for non-Escherichia coli isolates in a clinical microbiology laboratory remains problematic. We evaluated fosfomycin susceptibility by multiple methods with 96 KPC-producing clinical isolates of multiple strains and species collected at a single center between 2008 and 2016. In addition, we assessed the presence of fosfomycin resistance genes from whole-genome sequencing (WGS) data using NCBI's AMRFinder and custom HMM search. Susceptibility testing was performed using a glucose-6-phosphate-supplemented fosfomycin Etest and Kirby-Bauer disk diffusion (DD) assays, and the results were compared to those obtained by agar dilution. Clinical Laboratory and Standards Institute (CLSI) breakpoints for E. coli were applied for interpretation. Overall, 63% (60/96) of isolates were susceptible by Etest, 70% (67/96) by DD, and 88% (84/96) by agar dilution. fosA was detected in 80% (70/88) of previously sequenced isolates, with species-specific associations and alleles, and fosA-positive isolates were associated with higher MIC distributions. Disk potentiation testing was performed using sodium phosphonoformate to inhibit fosA and showed significant increases in the zone diameter of DD testing for isolates that were fosA positive compared to those that were fosA negative. The addition of sodium phosphonoformate (PPF) corrected 10/14 (71%) major errors in categorical agreement with agar dilution. Our results indicate that fosA influences the inaccuracy of susceptibility testing by methods readily available in a clinical laboratory compared to agar dilution. Further research is needed to determine the impact of fosA on clinical outcomes.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Elliott ZS, Barry KE, Cox HL, et al. The Role of fosA in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates. J Clin Microbiol. 2019. PMID: 31340992. doi:10.1128/JCM.00634-19

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。